HALOZYME THERAPEUT earnings per share and revenue

RV7 earnings per share for the last quarter are 0.98 CHF whereas the estimation was 0.82 CHF which accounts for 20.18% surprise. Company revenue for the same period amounts to 234.47 M CHF despite the estimated figure of 203.70 M CHF. Estimated earnings per share for the next quarter are 0.98 CHF, and revenue is expected to reach 226.92 M CHF. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.